Lakeside Discovery

Lakeside Discovery is a drug discovery accelerator formed through a strategic partnership between Northwestern University and Deerfield Management. Launched in 2018 with a funding commitment of up to $65 million, the venture is designed to bridge the gap between academic innovation and commercial drug development. The entity provides financial support and operational expertise to advance early-stage research from Northwestern's laboratories toward the Investigational New Drug (IND) stage. Lakeside Discovery focuses on a broad range of therapeutic areas, including oncology, neurology, and cardiovascular diseases, with the goal of translating breakthrough scientific discoveries into novel treatments for patients. By leveraging Deerfield's investment capabilities and Northwestern's scientific excellence, the partnership aims to accelerate the delivery of life-saving therapies to the market.